Today: 1 July 2026
Browse Category

Quantum Computing 25 November 2025 - 5 December 2025

SciSparc (SPRC) Stock on December 5, 2025: Price Action, Quantum Data Deal, GERD Device Pivot and 2030 Forecast

SciSparc (SPRC) Stock on December 5, 2025: Price Action, Quantum Data Deal, GERD Device Pivot and 2030 Forecast

SciSparc Ltd. is back on traders’ radar after a frenetic week of news that spans quantum bio‑data analytics, medical endoscopy devices and ongoing restructuring of its biotech portfolio. As of Friday, December 5, 2025, SciSparc shares are trading around $1.79–$1.80, after an early pre‑market jump of about 19% to $2.10, on volume that has already surged well above normal levels. StockAnalysis+1
5 December 2025
···
IonQ Stock Jumps After Quantum Breakthroughs and Biotech Deal: IONQ Price, Forecast and Outlook as of December 5, 2025

IonQ Stock Jumps After Quantum Breakthroughs and Biotech Deal: IONQ Price, Forecast and Outlook as of December 5, 2025

IonQ, Inc. is once again at the center of the quantum-computing spotlight. After a sharp pullback in November, the quantum hardware specialist has ripped higher into early December on the back of record-breaking technical milestones, a new biotech partnership, and rising institutional interest. As of the close on December 4, 2025, IonQ stock finished at $54.76, up 12.6% on the day, following a wave of renewed enthusiasm around government support for quantum technologies and a string of bullish Wall Street calls. StockAnalysis+1
5 December 2025
··
Rigetti Computing (RGTI) Stock: From 42% November Plunge to December Rebound – Latest News, Forecasts and Analysis (Dec 5, 2025)

Rigetti Computing (RGTI) Stock: From 42% November Plunge to December Rebound – Latest News, Forecasts and Analysis (Dec 5, 2025)

Rigetti Computing, Inc. has become one of 2025’s most volatile – and closely watched – quantum computing stocks. After plunging about 42% in November on weak revenue and governance worries, the share price abruptly rebounded in early December, jumping more than 15% on December 4 alone.sharewise.com+1 As of the morning of December 5, 2025, Rigetti trades around $30.06 per share, up roughly 17–18% over the last week and an extraordinary ~867% over the past year. The company’s market capitalization is just under $10 billion, despite trailing‑12‑month revenue of only about $7.5 million and negative EBITDA near $73 million, underscoring how much of the valuation rests on future expectations rather than current earnings.WallStreetZen+1
5 December 2025
··
Q/C Technologies (QCLS) Stock: Shkreli-Fueled Quantum-Class Rally, Latest News and Forecasts as of December 5, 2025

Q/C Technologies (QCLS) Stock: Shkreli-Fueled Quantum-Class Rally, Latest News and Forecasts as of December 5, 2025

Q/C Technologies, Inc. has suddenly gone from obscure microcap to social‑media star. Over just two trading sessions, the stock has effectively doubled after former pharma executive Martin Shkreli disclosed a position, floated a near‑term $100 price target, and hinted at wanting to run the company if regulators ever let him back into a C‑suite. Benzinga+2Stocktwits+2 Underneath the drama is a tiny company that recently pivoted from biotech into “quantum‑class” photonic computing and blockchain infrastructure, built around licensed light‑based processors from Israeli startup LightSolver. Streamlined+3Business Wire+3Business Wire+3
5 December 2025
·
Cisco Systems (CSCO) Stock Today: AI Infrastructure, Quantum Bets and Wall Street Targets – December 4, 2025

Cisco Systems (CSCO) Stock Today: AI Infrastructure, Quantum Bets and Wall Street Targets – December 4, 2025

Cisco Systems, Inc. is closing out 2025 as one of the quieter but more powerful AI infrastructure winners in large‑cap tech. As of the close on December 4, 2025, Cisco shares traded just under $78, near record territory after a roughly 30%+ year‑to‑date gain, with the stock sitting well above its 52‑week low of $52.11 and just below the high around $80.06.StockAnalysis+2Ticker Nerd+2 At the same time, a wave of fresh news, forecasts and analysis published on December 4, 2025 is sharpening the market’s view of what comes next: from new AI infrastructure announcements and OECD research on global AI adoption, to updated fair‑value estimates and institutional money flows.
4 December 2025
····
D-Wave Quantum (QBTS) Stock Surges on Government Push and Analyst Upgrades: Full 2025 Outlook and 2026 Forecast

D-Wave Quantum (QBTS) Stock Surges on Government Push and Analyst Upgrades: Full 2025 Outlook and 2026 Forecast

As of the afternoon on December 4, 2025, D‑Wave Quantum Inc. is trading around $28.37, up roughly 13% on the day, after hitting an intraday high of about $28.52 on heavy volume of more than 31 million shares. Over the last year, the stock has swung between $2.88 and $46.75, underscoring just how volatile this quantum computing pure‑play has become. MarketBeat Year to date, various analyses put QBTS up roughly 170%–200% in 2025, even after sharp pullbacks from its October peak near $46.75.Investors.com+1 That explosive move has pushed D‑Wave into the center of speculative tech trading, but it’s also being underpinned by real business developments:
4 December 2025
·
IonQ, Inc. (IONQ) Stock Jumps on Quantum-AI and Defense Deals: December 4, 2025 Outlook

IonQ, Inc. (IONQ) Stock Jumps on Quantum-AI and Defense Deals: December 4, 2025 Outlook

IonQ’s stock is having another very “on‑brand” quantum day: volatile, loud, and hard to ignore. Around midday on December 4, 2025, IonQ, Inc. was trading in the mid‑$50s, up double digits intraday after a string of headlines tying the company to biotech, defense drones, and big institutional money. StockAnalysis shows the shares around $54.20, up about 11%, in early afternoon trading. StockAnalysis+1
4 December 2025
····
Rigetti Computing (RGTI) Stock on December 4, 2025: Q3 Earnings Shock, Quantum Roadmap and 2026–2027 Forecasts

Rigetti Computing (RGTI) Stock on December 4, 2025: Q3 Earnings Shock, Quantum Roadmap and 2026–2027 Forecasts

Rigetti Computing, Inc. remains one of 2025’s wildest stories in quantum computing and in the broader U.S. stock market. After rocketing from penny‑stock territory in 2023 to a 2025 high above $58, the stock has just endured a brutal November sell‑off tied to Q3 2025 earnings, even as the company doubles down on an aggressive roadmap toward 1,000+ qubits and deep partnerships with NVIDIA, global research labs, and defense customers. StockScan+1 As of December 4, 2025, Rigetti shares trade around $28 per share, well below their October peak but still hundreds of percent higher than a year ago. StockAnalysis
4 December 2025
···
D-Wave Quantum (QBTS) Stock on December 3, 2025: New U.S. Government Unit, Evercore’s $44 Target and What It Means for Investors

D-Wave Quantum (QBTS) Stock on December 3, 2025: New U.S. Government Unit, Evercore’s $44 Target and What It Means for Investors

As of December 3, 2025, D-Wave Quantum Inc. is again at the center of the quantum-computing story on Wall Street. A new U.S. government-focused business unit, a fresh “Outperform” initiation from Evercore ISI with a $44 price target, and a flurry of valuation debates have turned the stock into one of the most closely watched high‑risk tech names on the market. TS2 Tech+2Quantum Zeitgeist+2 Below is a detailed, SEO-friendly rundown of today’s news, analyst forecasts, fundamentals, bull vs. bear arguments, and what could move QBTS next. This article is informational only and not investment advice.
3 December 2025
··
Rigetti Computing (RGTI) Stock on December 2, 2025: Price, Quantum Roadmap, Analyst Targets and Key Risks

Rigetti Computing (RGTI) Stock on December 2, 2025: Price, Quantum Roadmap, Analyst Targets and Key Risks

Updated: December 2, 2025 Rigetti Computing, Inc. remains one of the most volatile stories in quantum technology and on the Nasdaq. After a spectacular rally in 2025 and a sharp November pullback, fresh commentary on December 2 focuses on whether the latest “quantum dive” is a buying opportunity or a warning shot for investors.
2 December 2025
···
IonQ Stock (IONQ) in December 2025: Latest News, Analyst Forecasts, and Quantum Computing Risks Investors Need to Know

IonQ Stock (IONQ) in December 2025: Latest News, Analyst Forecasts, and Quantum Computing Risks Investors Need to Know

IonQ, Inc. remains one of the most closely watched pure‑play quantum computing stocks as of December 2, 2025. After a year of extreme volatility, the shares are trading around $47–48 per share, with an intraday range between roughly $46.8 and $49.2 and heavy trading volume. TS2 Tech The stock is still dramatically higher than it was a year ago, but sits well below its 2025 peak near $84, reflecting a tug‑of‑war between excitement over IonQ’s technical milestones and mounting concerns over valuation, dilution, and sector‑wide “quantum bubble” warnings. TS2 Tech+2TradingView+2
2 December 2025
··
QBTS Stock: D‑Wave Quantum Rises on New U.S. Government Unit – Price, Forecast & Analysis (December 2, 2025)

QBTS Stock: D‑Wave Quantum Rises on New U.S. Government Unit – Price, Forecast & Analysis (December 2, 2025)

D‑Wave Quantum’s stock is back in the spotlight today after the company unveiled a new U.S. government–focused business unit, extending one of 2025’s wildest stock market stories. By early afternoon on December 2, QBTS was trading around $21.8–$22.0 per share, up roughly 2% on the day, after moving between about $21.4 and $22.9 in intraday trading. That puts D‑Wave’s market cap around the $7.7–7.8 billionmark and leaves the stock sitting in a 52‑week range of roughly $2.50 to $46.75.Investing.com+1
2 December 2025
··
Rigetti Computing (RGTI) Stock on December 1, 2025: Options Surge, Institutional Buying and a High‑Risk Quantum Roadmap

Rigetti Computing (RGTI) Stock on December 1, 2025: Options Surge, Institutional Buying and a High‑Risk Quantum Roadmap

Rigetti Computing, Inc. remains one of 2025’s wildest quantum computing stories. On December 1, 2025, the RGTI stock price trades around the mid‑$20s, far below its recent peaks but still massively above where it began the year, as traders digest fresh options activity, new institutional positions, insider selling and a very ambitious quantum hardware roadmap. Yahoo Finance+1 For investors following quantum computing stocks, Rigetti now sits at the intersection of cutting‑edge physics and speculative growth investing: tiny revenues, huge losses, a big cash pile, and a valuation that prices in years of future success long before meaningful profits arrive. The Quantum Insider+2StockAnalysis+2
1 December 2025
···
IBM Stock Price Outlook Before the Market Opens on December 1, 2025: AI, Quantum and Dividends Drive NYSE:IBM Near Its Highs

IBM Stock Price Outlook Before the Market Opens on December 1, 2025: AI, Quantum and Dividends Drive NYSE:IBM Near Its Highs

As U.S. markets head into the first trading session of December 2025, International Business Machines Corporation is positioned just below its 52‑week high after a powerful multi‑month rally driven by artificial intelligence, hybrid cloud, mainframe upgrades and a rising quantum computing story. This article compiles the key IBM stock price moves, news, analyses and forecasts published between November 28–30, 2025, and sets the scene for traders and investors looking at IBM before the bell on Monday, December 1, 2025.
30 November 2025
·····
IBM Stock (NYSE: IBM) on 29 November 2025: Institutional Buying Surge, AI & Quantum Bets, and What It Means for Investors

IBM Stock (NYSE: IBM) on 29 November 2025: Institutional Buying Surge, AI & Quantum Bets, and What It Means for Investors

29 November 2025 International Business Machines Corporation heads into the final month of 2025 as one of the standout mega-cap tech performers of the year. The stock last closed at $308.58, near the upper end of its 52‑week range between $214.50 and $324.90, giving the company a market capitalization of roughly $288–289 billion.StockAnalysis+2INDmoney+2
29 November 2025
···
D-Wave Quantum (QBTS) Stock Today, November 26, 2025: Insider Selling, Cash Burn Fears and New Institutional Demand

D-Wave Quantum (QBTS) Stock Today, November 26, 2025: Insider Selling, Cash Burn Fears and New Institutional Demand

D-Wave Quantum Inc. is back in the spotlight today as new reports highlight heavy insider selling, record cash burn, and fresh institutional buying — all while the stock trades roughly flat in early afternoon trading. As of early afternoon U.S. trading on Wednesday, November 26, 2025, D-Wave Quantum stock is hovering around $22.70 per share, up about 0.5% on the day. The intraday range so far runs roughly between $22.01 and $22.94, on volume of about 15 million shares, below its recent hyper-active averages.
26 November 2025
·
Rigetti Computing (RGTI) Stock on November 25, 2025: Volatile Pullback as Insider Selling, NQI Funding and New ETF Collide

Rigetti Computing (RGTI) Stock on November 25, 2025: Volatile Pullback as Insider Selling, NQI Funding and New ETF Collide

Rigetti Computing, Inc. is back in the spotlight today as its hyper‑volatile stock trades lower despite fresh government funding tailwinds and the launch of a new ETF built directly on its shares. At the same time, insider selling and lofty valuations are keeping skeptics loud. As of early afternoon U.S. trading on November 25, 2025, RGTI changes hands around $25–26, down roughly 4–5% on the day, with more than 23 million shares traded. Over the past year the stock has swung between $2.10 and $58.15, giving the company a market capitalization of about $8.4 billion despite trailing‑12‑month revenue of only about $7.5 million and a net loss of roughly $351 million. StockAnalysis
25 November 2025
···
1 … 13 14 15 16 17 … 23

Stock Market Today

  • Kymera Therapeutics (KYMR) up 51% YTD as atopic dermatitis drug hits milestones
    July 1, 2026, 2:57 PM EDT. Kymera Therapeutics (KYMR) is up nearly 51% this year, way ahead of the sector's 6.4%. The stock's gain is tied to progress on KT-621, an oral STAT6 degrader for atopic dermatitis and asthma. Kymera wrapped phase IIb enrollment in the BROADEN2 AD trial six months early, aiming to have the pivotal readout by late 2026. Earlier, phase Ib data showed strong STAT6 knockdown and safety. The FDA put KT-621 on Fast Track for moderate-to-severe AD and eosinophilic asthma. Separately, trials for KT-485, in partnership with Sanofi, led to a $20 million milestone, and Kymera is still developing KT-579. Its alliances with Sanofi and Gilead are part of the company's long-term plans.
Go toTop